|
NEPH | Nephros Inc |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.26 |
| Leverage | 24.11% |
| Market Cap | $ 46.2m |
| PE | 26.65 |
| Dividend Yield | 0.00% |
| Profit | $ 1.7m |
| Margin | 8.41% |
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.